Report post
The FDA has removed Zepbound and Mounjaro from the drug shortage list, signaling the end of the tirzepatide compounding issue. The FDA manages drug shortages and regulates various aspects of pharmaceutical products to ensure safety and effectiveness. Its approval process is rigorous, covering new drugs, generics, biosimilars, and more. However, the FDA does not approve compounding practices directly. Understanding FDA's role is crucial for ensuring drug availability and safety.

The World's Leading Crypto Trading Platform

Get my welcome gifts